Prestige Consumer Healthcare Inc. Files 10-Q for Period Ending December 31, 2023

TL;DR

<b>Prestige Consumer Healthcare Inc. filed its Q3 2024 10-Q report on February 8, 2024, detailing financial performance for the period ending December 31, 2023.</b>

AI Summary

Prestige Consumer Healthcare Inc. (PBH) filed a Quarterly Report (10-Q) with the SEC on February 8, 2024. Prestige Consumer Healthcare Inc. filed a 10-Q report for the period ending December 31, 2023. The filing covers the third quarter of fiscal year 2024. The company's fiscal year ends on March 31st. The filing was made on February 8, 2024. Prestige Consumer Healthcare Inc. was formerly known as Prestige Brands Holdings, Inc. and Prestige Household Brands, Inc.

Why It Matters

For investors and stakeholders tracking Prestige Consumer Healthcare Inc., this filing contains several important signals. This filing provides investors with the latest financial performance data for Prestige Consumer Healthcare Inc., crucial for evaluating the company's current health and future prospects. Understanding the details within this 10-Q allows stakeholders to assess the company's revenue, expenses, and overall financial position as of the end of the third quarter of fiscal year 2024.

Risk Assessment

Risk Level: low — Prestige Consumer Healthcare Inc. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not indicate any immediate or significant financial distress or unusual events based on the header information alone.

Analyst Insight

Review the detailed financial statements and management discussion within the 10-Q to understand revenue trends, profitability, and any forward-looking statements made by Prestige Consumer Healthcare Inc.

Key Numbers

• 2023-12-31 — Period End Date (Conformed period of report)
• 2024-02-08 — Filing Date (Filed as of date)
• 0331 — Fiscal Year End (Fiscal year end)
• 2024 — Fiscal Quarter (Third quarter of fiscal year 2024)

Key Players & Entities

• Prestige Consumer Healthcare Inc. (company) — Filer name
• 2023-12-31 (date) — Conformed period of report
• 2024-02-08 (date) — Filed as of date
• 2834 (industry_code) — Standard Industrial Classification
• 660 WHITE PLAINS RD. (address) — Business address street 1
• TARRYTOWN (location) — Business address city
• NY (location) — Business address state
• 10591 (zip_code) — Business address zip

Forward-Looking Statements

• Prestige Consumer Healthcare Inc. will continue to focus on managing its equity structure, potentially through share repurchases given the mention of 'Treasury Stock Common'. (Prestige Consumer Healthcare Inc.) — medium confidence, target: 2024-03-31

FAQ

Industry Context

Prestige Consumer Healthcare Inc. operates within the pharmaceutical preparations industry, focusing on consumer healthcare products.

Regulatory Implications

The company is subject to standard SEC regulations for public filings, including the requirement to submit quarterly reports (10-Q) detailing financial performance and business operations.

What Investors Should Do

1. Analyze the revenue and net income figures for the reported quarter and year-to-date.
2. Examine any disclosed changes in assets, liabilities, and equity.
3. Review management's discussion and analysis for insights into operational performance and future outlook.

Key Dates

• 2024-02-08: 10-Q Filing — Report for the period ending December 31, 2023
• 2023-12-31: Reporting Period End — Financial data reflects performance up to this date
• 2024-03-31: Fiscal Year End — Indicates the end of the company's annual reporting cycle

Year-Over-Year Comparison

This is the initial analysis of the 10-Q filing for the period ending December 31, 2023. Comparative data from previous filings would be needed for a full comparison.

Key Financial Figures

• $0.01 — ich registered Common stock, par value $0.01 per share PBH New York Stock Exchange

Filing Documents

• pbh-20231231.htm (10-Q) — 1442KB
• exhibit3112023-12x31.htm (EX-31.1) — 11KB
• exhibit3122023-12x31.htm (EX-31.2) — 11KB
• exhibit3212023-12x31.htm (EX-32.1) — 5KB
• exhibit3222023-12x31.htm (EX-32.2) — 5KB
• pbh-20231231_g1.jpg (GRAPHIC) — 65KB
• 0001295947-24-000008.txt (&nbsp;) — 7852KB
• pbh-20231231.xsd (EX-101.SCH) — 50KB
• pbh-20231231_cal.xml (EX-101.CAL) — 112KB
• pbh-20231231_def.xml (EX-101.DEF) — 189KB
• pbh-20231231_lab.xml (EX-101.LAB) — 641KB
• pbh-20231231_pre.xml (EX-101.PRE) — 400KB
• pbh-20231231_htm.xml (XML) — 1374KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Condensed Consolidated Statements of Income and Comprehensive Income for the three and nine months ended December 31, 2023 and 2022 (unaudited) 2 Condensed Consolidated Balance Sheets as of December 31, 2023 and March 31, 2023 (unaudited) 3 Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended December 31, 2023 and 2022 (unaudited) 4 Condensed Consolidated Statements of Cash Flows for the three and nine months ended December 31, 2023 and 2022 (unaudited) 6 Notes to Condensed Consolidated Financial Statements (unaudited) 7

Management's Discussion and Analysis of Financial Condition and Results of Operations 22

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 22

Quantitative and Qualitative Disclosures About Market Risk 33

Item 3. Quantitative and Qualitative Disclosures About Market Risk 33

Controls and Procedures 33

Item 4. Controls and Procedures 33

OTHER INFORMATION

PART II. OTHER INFORMATION

Risk Factors 33

Item 1A. Risk Factors 33

Exhibits 35

Item 6. Exhibits 35 Signatures 36 TRADEMARKS AND TRADE NAMES Trademarks and trade names used in this Quarterly Report on Form 10-Q are the property of Prestige Consumer Healthcare Inc. or its subsidiaries, as the case may be. We have italicized our trademarks and trade names when they appear in this Quarterly Report on Form 10-Q. -1-

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Prestige Consumer Healthcare Inc . Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) Three Months Ended December 31, Nine Months Ended December 31, (In thousands, except per share data) 2023 2022 2023 2022 Revenues Net sales $ 282,715 $ 275,495 $ 848,321 $ 841,783 Other revenues 26 29 45 73 Total revenues 282,741 275,524 848,366 841,856 Cost of Sales Cost of sales excluding depreciation 122,794 123,251 369,772 364,631 Cost of sales depreciation 2,009 1,871 5,963 5,695 Cost of sales 124,803 125,122 375,735 370,326 Gross profit 157,938 150,402 472,631 471,530 Operating Expenses Advertising and marketing 39,466 30,423 115,799 114,193 General and administrative 26,003 26,536 79,687 79,688 Depreciation and amortization 5,637 6,259 16,869 19,067 Total operating expenses 71,106 63,218 212,355 212,948 Operating income 86,832 87,184 260,276 258,582 Other expense Interest expense, net 16,575 17,917 51,900 50,188 Other expense (income), net 682 1,150 ( 327 ) 2,787 Total other expense, net 17,257 19,067 51,573 52,975 Income before income taxes 69,575 68,117 208,703 205,607 Provision for income taxes 16,529 16,166 48,822 47,361 Net income $ 53,046 $ 51,951 $ 159,881 $ 158,246 Earnings per share: Basic $ 1.07 $ 1.05 $ 3.21 $ 3.17 Diluted $ 1.06 $ 1.04 $ 3.19 $ 3.14 Weighted average shares outstanding: Basic 49,740 49,693 49,731 49,919 Diluted 50,125 50,186 50,134 50,392 Comprehensive income, net of tax: Currency translation adjustments 7,465 6,970 3,035 ( 9,667 ) Net loss on termination of pension plan — — — ( 790 ) Total other comprehensive income (loss) 7,465 6,970 3,035 ( 10,457 ) Comprehensive income $ 60,511 $ 58,921 $ 162,916 $ 147,789 See accompanying notes. -2- Prestige Consumer Healthcare Inc. Condensed Consolidated Balance Sheets ( Unaudited ) (In thousands) December 31, 2023 March 31, 2023 Assets Current assets Cash and cash equivalents $ 63,615

View Full Filing

View this 10-Q filing on SEC EDGAR